ELV

#185
Elevance Health, Inc. Common Stock
405.7 1 USD
+0.01%
Market Price
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
405.16
407.63
Jahresspanne
274.84
434.38
Tagesänderung
+0.65%
Monatliche Änderung
+6.00%
6 month change
+42.71%
Jahresänderung
+31.54%
Vorheriger Schlusskurs
403.0 8
Open
406.9 1
Tief
405.1 6
Hoch
407.6 3
Volumen
795
Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik Dividenden Documents

2026

Current report, Q3 FY2026
Elevance Health, Inc. current report, Q3 FY2026
8-K
Quarterly report, Q2 FY2026
Elevance Health, Inc. quarterly report, Q2 FY2026
10-Q
Current report, Q2 FY2026
Elevance Health, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Elevance Health, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Elevance Health, Inc. current report, Q2 FY2026
8-K
Quarterly report, Q1 FY2026
Elevance Health, Inc. quarterly report, Q1 FY2026
10-Q
Current report, Q1 FY2026
Elevance Health, Inc. current report, Q1 FY2026
8-K
Current report, Q1 FY2026
Elevance Health, Inc. current report, Q1 FY2026
8-K
Current report, Q1 FY2026
Elevance Health, Inc. current report, Q1 FY2026
8-K
Current report, Q1 FY2026
Elevance Health, Inc. current report, Q1 FY2026
8-K

Elevance Health, Inc. current report, Q2 FY2010

Full document

Business Context and Reporting Period

This Form 8-K filing by WellPoint, Inc. (now Elevance Health, Inc.) reports on the Annual Meeting of Shareholders held on May 18, 2010. The report details the voting results for director elections, auditor ratification, and several shareholder proposals.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document focuses exclusively on corporate governance and shareholder voting outcomes.

Material Changes and Voting Results

  • Director Elections: All three nominees (Sheila P. Burke, George A. Schaefer, Jr., and Jackie M. Ward) were elected to three-year terms expiring in 2013. Each nominee received approximately 287 million to 292 million votes "For," with roughly 37 million to 42 million votes "Against."
  • Auditor Ratification: Shareholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for 2010 with 347.8 million votes "For" versus 2.7 million "Against."
  • Shareholder Proposals:
    • Non-profit Status Study: Rejected (30.5 million "For" vs. 293.3 million "Against").
    • Lobbying Expense Disclosure: Rejected (49.8 million "For" vs. 215.1 million "Against").
    • Delaware Incorporation: Rejected (124.4 million "For" vs. 199.9 million "Against").
    • "Say on Pay" Proposal: Approved (198.8 million "For" vs. 117.5 million "Against"). Shareholders voted to adopt a policy for non-binding advisory votes on executive compensation at each annual meeting.

Guidance, Outlook, and Risks

The filing text does not provide a clear value for financial guidance, future outlook, management commentary on operations, or specific risk factors. The document is limited to the procedural results of the shareholder meeting.

Key Facts for Investor Verification

  • Verify the implementation timeline for the newly approved "Say on Pay" advisory vote policy.
  • Confirm the composition of the Board of Directors following the election of the three new directors.
  • Review the definitive Proxy Statement filed on April 2, 2010, for detailed context on the rejected proposals regarding non-profit status and lobbying disclosures.
  • Note the significant number of broker non-votes (20.3 million) recorded across all matters, indicating shares held in street name where brokers lacked discretionary voting authority.

Nachrichten